Hafrun Fridriksdottir, Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 58,992 shares at $12.69 ($749K) on 2021-02-09, disclosed to the SEC on 2021-02-11.
Open-market sale of $749k TEVA by Executive VP, Global R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.69 | 5,857 | $74K | 9.9% |
| 2 | $12.69 | 5,857 | $74K | 9.9% |
| 3 | $12.69 | 23,639 | $300K | 40.1% |
| 4 | $12.69 | 23,639 | $300K | 40.1% |
| Total | $12.69 avg | 58,992 | $749K | 100% |
| Filing → |
| TEVA | SELL | 2022-03-02 | $124K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $111K | — | Filing → |
| TEVA | SELL | 2021-08-12 | $1.0M | — | Filing → |